OMX Copenhagen 20
1.551,52
PKT
+9,04
PKT
+0,59
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.10.12 | Novo Nordisk buy | UBS AG | |
| 04.10.12 | Novo Nordisk buy | UBS AG | |
| 04.10.12 | A.P. Moeller - Maersk A-S (B) neutral | UBS AG | |
| 03.10.12 | Carlsberg buy | Nomura | |
| 28.09.12 | Danske Bank underperform | Exane-BNP Paribas SA | |
| 28.09.12 | Carlsberg overweight | Morgan Stanley | |
| 27.09.12 | A.P. Moeller - Maersk A-S (B) overweight | Morgan Stanley | |
| 27.09.12 | Carlsberg sell | ING | |
| 24.09.12 | Carlsberg hold | ING | |
| 21.09.12 | Novo Nordisk buy | UBS AG | |
| 17.09.12 | FFLSmidth neutral | Exane-BNP Paribas SA | |
| 14.09.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 14.09.12 | Carlsberg neutral | J.P. Morgan Cazenove | |
| 14.09.12 | Danske Bank overweight | J.P. Morgan Cazenove | |
| 13.09.12 | Carlsberg hold | ING | |
| 11.09.12 | Carlsberg hold | ING | |
| 11.09.12 | Novo Nordisk neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novo Nordisk neutral | Nomura | |
| 05.09.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 05.09.12 | Carlsberg buy | Nomura | |
| 03.09.12 | Novozymes A-S (B) buy | ING | |
| 30.08.12 | DSV A-S neutral | Banc of America Securities-Merrill Lynch | |
| 28.08.12 | A.P. Moeller - Maersk A-S (B) neutral | Nomura | |
| 28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 24.08.12 | DSV A-S reduce | Nomura | |
| 24.08.12 | DSV A-S buy | Nomura | |
| 17.08.12 | Carlsberg hold | Deutsche Bank AG | |
| 17.08.12 | Carlsberg hold | Société Générale Group S.A. (SG) | |
| 16.08.12 | Carlsberg neutral | UBS AG | |
| 16.08.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 16.08.12 | Carlsberg buy | Nomura | |
| 16.08.12 | Carlsberg sector perform | RBC Capital Markets | |
| 14.08.12 | Carlsberg hold | ING | |
| 14.08.12 | Carlsberg equal-weight | Morgan Stanley | |
| 10.08.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 10.08.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 09.08.12 | Novo Nordisk neutral | Sarasin Research | |
| 09.08.12 | A.P. Moeller - Maersk A-S (B) neutral | J.P. Morgan Cazenove | |
| 09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 08.08.12 | Danske Bank reduce | Nomura |